162 related articles for article (PubMed ID: 10364085)
1. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
[TBL] [Abstract][Full Text] [Related]
2. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
[TBL] [Abstract][Full Text] [Related]
4. Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites.
Pulinilkunnil T; Abrahani A; Varghese J; Chan N; Tang I; Ghosh S; Kulpa J; Allard M; Brownsey R; Rodrigues B
J Mol Cell Cardiol; 2003 Sep; 35(9):1093-103. PubMed ID: 12967632
[TBL] [Abstract][Full Text] [Related]
5. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Liu L; Severson DL
Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
[TBL] [Abstract][Full Text] [Related]
6. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Rodrigues B; Severson DL
Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
Sambandam N; Abrahani MA; Craig S; Al-Atar O; Jeon E; Rodrigues B
Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1874-82. PubMed ID: 10843884
[TBL] [Abstract][Full Text] [Related]
8. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
[TBL] [Abstract][Full Text] [Related]
9. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
Sambandam N; Lim F; Cam MC; Rodrigues B
J Cardiovasc Pharmacol; 1997 Jul; 30(1):110-7. PubMed ID: 9268229
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
Braun JE; Severson DL
Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
[TBL] [Abstract][Full Text] [Related]
11. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
Liu L; Severson DL
Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
[TBL] [Abstract][Full Text] [Related]
12. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase.
An D; Pulinilkunnil T; Qi D; Ghosh S; Abrahani A; Rodrigues B
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E246-53. PubMed ID: 15328075
[TBL] [Abstract][Full Text] [Related]
13. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
Braun JE; Severson DL
Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
Niu YG; Evans RD
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
[TBL] [Abstract][Full Text] [Related]
15. Cardiac lipoprotein lipase in the spontaneously hypertensive rat.
Sambandam N; Chen X; Cam MC; Rodrigues B
Cardiovasc Res; 1997 Feb; 33(2):460-8. PubMed ID: 9074711
[TBL] [Abstract][Full Text] [Related]
16. Palmitoyl lysophosphatidylcholine mediated mobilization of LPL to the coronary luminal surface requires PKC activation.
Pulinilkunnil T; An D; Yip P; Chan N; Qi D; Ghosh S; Abrahani A; Rodrigues B
J Mol Cell Cardiol; 2004 Nov; 37(5):931-8. PubMed ID: 15522270
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Ewart HS; Carroll R; Severson DL
Can J Physiol Pharmacol; 1999 Aug; 77(8):571-8. PubMed ID: 10543720
[TBL] [Abstract][Full Text] [Related]
18. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
Rodrigues B; Spooner M; Severson DL
Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
[TBL] [Abstract][Full Text] [Related]
19. Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism.
Qi D; Pulinilkunnil T; An D; Ghosh S; Abrahani A; Pospisilik JA; Brownsey R; Wambolt R; Allard M; Rodrigues B
Diabetes; 2004 Jul; 53(7):1790-7. PubMed ID: 15220203
[TBL] [Abstract][Full Text] [Related]
20. Contribution of hyperinsulinemia to modulation of lipoprotein lipase activity in the obese Zucker rat.
Boivin A; Deshaies Y
Metabolism; 2000 Jan; 49(1):134-40. PubMed ID: 10647077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
